AceLink Therapeutics kickstarts Phase 2 Fabry disease clinical trials in China

In a pivotal move, AceLink Therapeutics, Inc., a frontrunner in the biopharmaceutical sector, has inaugurated its first clinical trial site in China. The Phase 2, ... Read More